Please assess the completion status of the following clinical trial:

Trial Title: Basal/Bolus Versus Sliding Scale Insulin In Hospitalized Patients With Type 2 Diabetes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Males or females between the ages of 18 and 70 years admitted to a general medicine service.~2. A known history of type 2 diabetes mellitus \> 3 months, receiving either diet alone or any combination of oral antidiabetic agents (sulfonylureas, metformin, thiazolidinediones).~3. Subjects must have an admission blood glucose \> 140 mg and \< 400 mg/dL without laboratory evidence of diabetic ketoacidosis (serum bicarbonate \< 18 mEq/L or positive serum or urinary ketones).~Exclusion Criteria:~1. Subjects with increased blood glucose concentration, but without a known history of diabetes.~2. Subjects with a history of diabetic ketoacidosis and hyperosmolar hyperglycemic state, or ketonuria \[57\].~3. Patients with known HIV, acute critical or surgical illness and/or expected to require admission to a critical care unit (ICU, CCU), corticosteroid therapy, or to undergo surgery during the hospitalization course.~4. Patients with clinically relevant hepatic disease or impaired renal function, as shown by a serum creatinine ≥3.0.~5. Mental condition rendering the subject unable to understand the nature, scope, and possible consequences of the study.~6. Patients with recognized or suspected endocrine disorders associated with increased insulin resistance, acromegaly, or hyperthyroidism.~7. Female subjects are pregnant or breast feeding at time of enrollment into the study.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- sliding scale regular insulin (Type: ACTIVE_COMPARATOR): sliding scale insulin given acqhs
- glargine insulin and glulisine insulin (Type: ACTIVE_COMPARATOR): glargine basal insulin once a day with prandial glulisine insulin tid

Based on this trial design, predict the completion outcome and termination type (if applicable).